Europe Benign Prostatic Hyperplasia Market and Competitive Landscape - 2017

  • ID: 4377714
  • Report
  • Region: Europe
  • Fore Pharma
1 of 3
The latest research, Europe Benign Prostatic Hyperplasia Market and Competitive Landscape - 2017, provides comprehensive insights into Benign Prostatic Hyperplasia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Benign Prostatic Hyperplasia market size and drug sales. This research also provides insights into Benign Prostatic Hyperplasia epidemiology and late stage pipeline.

The report is classified into nine sections - Benign Prostatic Hyperplasia overview with definitions, symptoms, etiology, diagnosis, treatment options; Benign Prostatic Hyperplasia pipeline insights covering late stage clinical trials pipeline; Benign Prostatic Hyperplasia prevalence trends by countries; Benign Prostatic Hyperplasia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:
  • Benign Prostatic Hyperplasia pipeline: Find out the drugs in clinical trials for Benign Prostatic Hyperplasia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Benign Prostatic Hyperplasia epidemiology: Find out the prevalence of Benign Prostatic Hyperplasia by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Benign Prostatic Hyperplasia products: Identify key products marketed and prescribed for Benign Prostatic Hyperplasia by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Benign Prostatic Hyperplasia market size: Find out the market size for Benign Prostatic Hyperplasia drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Benign Prostatic Hyperplasia drug sales: Find out the sales of Benign Prostatic Hyperplasia drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Benign Prostatic Hyperplasia drugs sales forecast: Sales forecast for Benign Prostatic Hyperplasia drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Benign Prostatic Hyperplasia market share analysis: Find out the market shares of Benign Prostatic Hyperplasia drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Benign Prostatic Hyperplasia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Benign Prostatic Hyperplasia market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Benign Prostatic Hyperplasia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Benign Prostatic Hyperplasia: Disease Overview
1.1. Benign Prostatic Hyperplasia Symptoms
1.2. Benign Prostatic Hyperplasia Etiology
1.3. Benign Prostatic Hyperplasia Diagnosis
1.4. Benign Prostatic Hyperplasia Treatment Options

2. Benign Prostatic Hyperplasia Pipeline Insights
2.1. Benign Prostatic Hyperplasia Phase 3 Clinical Trials
2.2. Benign Prostatic Hyperplasia Phase 2 Clinical Trials
2.3. Benign Prostatic Hyperplasia Phase 1 Clinical Trials

3. Benign Prostatic Hyperplasia Epidemiology Analysis

4. Germany Benign Prostatic Hyperplasia Market Insights
4.1. Marketed Products for Benign Prostatic Hyperplasia in Germany
4.2. Germany Benign Prostatic Hyperplasia Market Size & Forecast
4.3. Germany Benign Prostatic Hyperplasia Product Sales Forecast
4.4. Germany Benign Prostatic Hyperplasia Market Share Analysis

5. France Benign Prostatic Hyperplasia Market Insights
5.1. Marketed Products for Benign Prostatic Hyperplasia in France
5.2. France Benign Prostatic Hyperplasia Market Size & Forecast
5.3. France Benign Prostatic Hyperplasia Product Sales Forecast
5.4. France Benign Prostatic Hyperplasia Market Share Analysis

6. Italy Benign Prostatic Hyperplasia Market Insights
6.1. Marketed Products for Benign Prostatic Hyperplasia in Italy
6.2. Italy Benign Prostatic Hyperplasia Market Size & Forecast
6.3. Italy Benign Prostatic Hyperplasia Product Sales Forecast
6.4. Italy Benign Prostatic Hyperplasia Market Share Analysis

7. Spain Benign Prostatic Hyperplasia Market Insights
7.1. Marketed Products for Benign Prostatic Hyperplasia in Spain
7.2. Spain Benign Prostatic Hyperplasia Market Size & Forecast
7.3. Spain Benign Prostatic Hyperplasia Product Sales Forecast
7.4. Spain Benign Prostatic Hyperplasia Market Share Analysis

8. UK Benign Prostatic Hyperplasia Market Insights
8.1. Marketed Products for Benign Prostatic Hyperplasia in UK
8.2. UK Benign Prostatic Hyperplasia Market Size & Forecast
8.3. UK Benign Prostatic Hyperplasia Product Sales Forecast
8.4. UK Benign Prostatic Hyperplasia Market Share Analysis

9. Europe Benign Prostatic Hyperplasia Market Insights
9.1. Europe Benign Prostatic Hyperplasia Market Size & Forecast
9.2. Europe Benign Prostatic Hyperplasia Product Sales Forecast
9.3. Europe Benign Prostatic Hyperplasia Market Share Analysis

10. Research Methodology

List of Tables:
Table 1: Benign Prostatic Hyperplasia Phase 3 Clinical Trials, Global, 2017
Table 2: Benign Prostatic Hyperplasia Phase 2 Clinical Trials, Global, 2017
Table 3: Benign Prostatic Hyperplasia Phase 1 Clinical Trials, Global, 2017
Table 4: Benign Prostatic Hyperplasia Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Benign Prostatic Hyperplasia in Germany, 2017
Table 6: Germany Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Benign Prostatic Hyperplasia Product Sales ($mn), 2012 - 2021
Table 8: Germany Benign Prostatic Hyperplasia Market Trends, 2012 - 2021
Table 9: Marketed Products for Benign Prostatic Hyperplasia in France, 2017
Table 10: France Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Benign Prostatic Hyperplasia Product Sales ($mn), 2012 - 2021
Table 12: France Benign Prostatic Hyperplasia Market Trends, 2012 - 2021
Table 13: Marketed Products for Benign Prostatic Hyperplasia in Italy, 2017
Table 14: Italy Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Benign Prostatic Hyperplasia Product Sales ($mn), 2012 - 2021
Table 16: Italy Benign Prostatic Hyperplasia Market Trends, 2012 - 2021
Table 17: Marketed Products for Benign Prostatic Hyperplasia in Spain, 2017
Table 18: Spain Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Benign Prostatic Hyperplasia Product Sales ($mn), 2012 - 2021
Table 20: Spain Benign Prostatic Hyperplasia Market Trends, 2012 - 2021
Table 21: Marketed Products for Benign Prostatic Hyperplasia in UK, 2017
Table 22: UK Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Benign Prostatic Hyperplasia Product Sales ($mn), 2012 - 2021
Table 24: UK Benign Prostatic Hyperplasia Market Trends, 2012 - 2021
Table 25: Europe Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Benign Prostatic Hyperplasia Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Benign Prostatic Hyperplasia Pipeline by Phase (%), Global, 2017
Figure 2: Benign Prostatic Hyperplasia Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Benign Prostatic Hyperplasia Market Size ($mn), 2012 - 2021
Figure 4: Germany Benign Prostatic Hyperplasia Product Sales ($mn), 2012 - 2021
Figure 5: Germany Benign Prostatic Hyperplasia Market Share by Products (%), 2016
Figure 6: Germany Benign Prostatic Hyperplasia Market - Future Market Share (%), 2021
Figure 7: France Benign Prostatic Hyperplasia Market Size ($mn), 2012 - 2021
Figure 8: France Benign Prostatic Hyperplasia Product Sales ($mn), 2012 - 2021
Figure 9: France Benign Prostatic Hyperplasia Market Share by Products (%), 2016
Figure 10: France Benign Prostatic Hyperplasia Market - Future Market Share (%), 2021
Figure 11: Italy Benign Prostatic Hyperplasia Market Size ($mn), 2012 - 2021
Figure 12: Italy Benign Prostatic Hyperplasia Product Sales ($mn), 2012 - 2021
Figure 13: Italy Benign Prostatic Hyperplasia Market Share by Products (%), 2016
Figure 14: Italy Benign Prostatic Hyperplasia Market - Future Market Share (%), 2021
Figure 15: Spain Benign Prostatic Hyperplasia Market Size ($mn), 2012 - 2021
Figure 16: Spain Benign Prostatic Hyperplasia Product Sales ($mn), 2012 - 2021
Figure 17: Spain Benign Prostatic Hyperplasia Market Share by Products (%), 2016
Figure 18: Spain Benign Prostatic Hyperplasia Market - Future Market Share (%), 2021
Figure 19: UK Benign Prostatic Hyperplasia Market Size ($mn), 2012 - 2021
Figure 20: UK Benign Prostatic Hyperplasia Product Sales ($mn), 2012 - 2021
Figure 21: UK Benign Prostatic Hyperplasia Market Share by Products (%), 2016
Figure 22: UK Benign Prostatic Hyperplasia Market - Future Market Share (%), 2021
Figure 23: Europe Benign Prostatic Hyperplasia Market Size ($mn), 2012 - 2021
Figure 24: Europe Benign Prostatic Hyperplasia Product Sales ($mn), 2012 - 2021
Figure 25: Europe Benign Prostatic Hyperplasia Market Share by Products (%), 2016
Figure 26: Europe Benign Prostatic Hyperplasia Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll